Computerized screening measures can provide valuable information on cognition. However, determining the validity of obtained data is critical for interpretation. The purpose of this study was to examine the embedded validity indicators on the CNS Vital Signs battery in a sample of youth with neurological diagnoses. The sample included 275 children and adolescents (mean ¼ 13.9, SD ¼ 3.0) with neurological disorders. Six out of seven subtests and six of the nine domain scores on CNS Vital Signs had fewer than 5% of the sample flagged as invalid on the embedded indicators. However, the Shifting Attention Test and its derived domain scores had higher rates of being flagged. Patients with one or more flagged scores (18% of sample) were younger and had lower intellectual abilities, psychomotor speed, verbal memory, and performance on other validity tests. Compared to stand-alone validity tests, CNS Vital Signs embedded validity indicators had low sensitivity. More research is needed with the embedded indicators in youth.
Introduction
Determining the validity of obtained patient data is an important component of a neuropsychological assessment (Bush et al., 2005; Heilbronner, Sweet, Morgan, Larrabee, & Millis, 2009; . Compared with adult studies, the literature on validity measurement in children is small, relatively underdeveloped, and slowly increasing over time (see Kirkwood, 2012) . The majority of pediatric studies have focused on stand-alone performance validity tests (PVTs) and have demonstrated that they can be readily passed by healthy children and adolescents (Constantinou & McCaffrey, 2003; Rienstra, Spaan, &Blaskewitz, Merten, and Kathman (2008) reported very low pass rates in healthy children, including 30% for second graders, 38% for third graders, and 60% for fourth graders. In a sample of adolescents with mild traumatic brain injuries, Kirkwood, Hargrave, and Kirk (2011) reported a 31% false-positive rate using the adult RDS cutoff. Suggestions for pediatric RDS cutoffs that provide at least 90% specificity have been RDS ≤ 6 in patients with mTBI (sensitivity ¼ 0.51; Kirkwood et al., 2011) , RDS ≤ 4 in a mixed clinical sample (sensitivity ¼ 0.43; Loughan et al., 2012) , and RDS ≤ 3 in patients with epilepsy (sensitivity ¼ 0.20; Welsh, Bender, Whitman, Vasserman, & MacAllister, 2012) .
Some studies have examined embedded validity indicators for pediatric memory measures. Baker, Connery, Kirk, and Kirkwood (2014) reported that a recognition discriminability score from the California Verbal Learning Test, Children's Version (CVLT-C; Delis, Kramer, Kaplan, & Ober, 1994) of z ¼ 20.5 could have 55% sensitivity for poor engagement (with a specificity of 91%) in youth referred clinically due to an mTBI. Perna, Loughan, Hertza, and Segraves (2014) suggested that a 20-point difference between the Children's Memory Scale (Cohen, 1997) Verbal Delayed Recall and Verbal Delayed Recognition could meet a recommended 90% specificity rate for children referred for academic or behavioral problems, but this level of discrepancy only provided an 11% sensitivity rate. Overall, these results suggest that embedded validity indicators may have potential use with pediatric patients, but considerable caution needs to be exercised due to the chances of higher false-positive rates and lack of strong supportive evidence.
A potential advantage of embedded validity indicators is that additional tests might not need to be administered to determine performance validity. This is most advantageous when faced with time constraints, such as when rapidly screening cognitive abilities, and for providing evidence of performance validity on a specific cognitive measure (rather than through a proxy measure). The CNS Vital Signs, a rapid computer-assisted battery of tests that provides a screen of cognitive abilities and has been used previously with pediatric patients (Brooks & Barlow, 2011; Brooks, Iverson, Sherman, & Roberge, 2010; , contains embedded validity indicators that are automatically calculated by the program. According to the publishers of the CNS Vital Signs battery, the embedded validity indicators were developed to " . . . indicate whether the patient gave poor effort or generated invalid results" (p. 5; CNS Vital Signs, 2014). However, despite the creation of validity indicators by the test publisher, there are no peer-reviewed manuscripts demonstrating the use and validity of these indicators with clinical populations. There have been four unpublished studies, presented at conferences that have examined performance validity on CNS Vital Signs. The first set of embedded validity indicators were introduced by Gualtieri, Vaishnavi, and Hervey (2009) . These authors reported high specificity rates in healthy control participants and in multiple clinical samples. Rohling, Hill, Ploetz, Womble, and Shenessey (2011) introduced a different set of embedded validity indicators and showed that they could detect university students instructed to malinger. Two studies examined the rated of invalid test scores in adults with depression (Saffer, Iverson, Kjernisted, & McIntosh, 2013) and in older adults referred for a cognitive assessment (Saffer, Rosenblatt, Lanting, Koehle, & Iverson, 2013) . For the study with adults with depression , participants were 48 outpatients who were enrolled in a treatment study. They completed the CNS Vital Signs battery three times (at a 1-week interval and again after 8 weeks). Applying the published validity indicators, 19.6% were identified as having invalid scores at time 1, 13.0% at time 2, and 10.9% at time 3. For the second study (Saffer, Rosenblatt, et al., 2013) , participants were 71 older adults who self-referred or were referred by their physicians for a cognitive screening evaluation. Based on the embedded validity indicators, six (8.5%) were identified as having invalid scores. For five of the six participants, their scores were out-of-range (i.e., standard score ,40) and the examiner noted that the participant did not appear to do the test properly. These studies suggest that a minority of adults and older adults with no known incentive for underperformance on testing have invalid scores on CNS Vital Signs.
The ability to determine the validity of CNS Vital Signs performance is an asset of this battery, particularly in clinical situations where there is a desire to rapidly screen cognitive functioning. However, information is needed on the sensitivity and specificity of these embedded validity indicators so that researchers and clinicians can have confidence in their use. The purpose of this study was to examine the prevalence rates, sensitivity and specificity of the CNS Vital Signs embedded validity indicators in a sample of children and adolescents with neurological disorders. Although there is not a consensus on acceptable rates of sensitivity and specificity for embedded validity indicators, it was our a priori decision that desirable levels would be set at 0.5 for sensitivity and 0.9 for specificity based on the abovementioned existing studies with youth.
Methods

Participants
The participants for this study were children and adolescents between 7 and 18 years of age who were assessed through a neuropsychology service at a tertiary care pediatric hospital. Because the neuropsychological assessments were completed as part of a clinical service, not every patient who was seen was given all the tests in the standard battery (i.e., the determination of which tests to include was up to the individual neuropsychologist). Therefore, this represented a sample of convenience rather than a prospective, consecutive series of patients. It reflects a more typical patient population seen by neuropsychologists working in tertiary care centers. Patients were excluded, and therefore not administered the CNS Vital Signs, if they were unable to understand test directions, unable to read words printed on a screen, or had motor or vision impairments that prevented test administration. A portion of this sample was previously reported in . The University of Calgary Conjoint Health Research Ethics Board granted ethical clearance for the collection and use of these data (REB13-0515).
Measures
CNS Vital Signs battery. CNS Vital Signs is a computer-administered battery of seven neuropsychological tests that are designed to rapidly screen cognitive abilities. The Verbal Memory Test involves immediate and delayed recognition for 15 words presented on the screen (drawn from a reservoir of 100 words). The same paradigm is followed for the Visual Memory Test, with immediate and delayed recognition of 15 geometric figures (drawn from a reservoir of 45 designs). For the Finger Tapping Test, participants are asked to rapidly press the space bar with their index finger (separately for right and left hands). The Symbol Digit Coding Test involves typing numbers that correspond to eight different symbols presented on the screen (drawn from a reservoir of 32 symbols). The Stroop Test contains three parts that involve responding to words and colors. Part one involves pressing the space bar as soon as the word RED, YELLOW, BLUE, or GREEN is shown on the screen (printed in black). Part two involves pressing the space bar when the color of the word matches what the word says (e.g., the word RED in red ink) but not responding when the color of the word does not match what the word says (e.g., RED printed in blue ink). Part three involves pressing the space bar when the color of the word does not match what the word says (e.g., RED printed in blue ink) but not responding when the color of the word matches what the word says (e.g., RED printed in red ink). The Shifting Attention Test involves matching geometric objects either by shape or by color (the match "rule" is alternated). The Continuous Performance Test is a 5-min sustained attention test that involves responding to the target stimulus "B" but not to any other letter.
The CNS Vital Signs primary domain scores (mean ¼ 100, SD ¼ 15; index scores for this study had a maximum range of 24 to +4 SDs, with low scores truncated at 40) are derived from performance on the seven tests (which together generate 18 subtest scores). Correct responses from the verbal and visual memory tests provide Verbal Memory and Visual Memory domain scores, respectively, as well as a composite Memory domain score. The total of right and left taps from the Finger Tapping Test and the total correct responses on the Symbol Digit Coding Test generate a composite score for Psychomotor Speed. Averaging the two complex reaction time scores from the Stroop Test generates a domain score for Reaction Time, which can be considered as measuring information processing speed in a test of executive function. The number of correct responses on the Shifting Attention Test, minus the number of errors on the Shifting Attention Test and the Stroop Test, is used to create a domain score for Cognitive Flexibility. A domain score for Complex Attention is generated by adding the number of errors committed in the Continuous Performance Test, the Shifting Attention Test, and the Stroop Test. Additional domain scores include Processing Speed (derived from performance on the Symbol Digit Coding Test) and Executive Functions (derived from performance on the Shifting Attention Test). The overall summary score, called the Neurocognition Index, is the average of the five original domain scores (Memory, Psychomotor Speed, Reaction Time, Complex Attention, and Cognitive Flexibility).
Each CNS Vital Signs subtest has an embedded validity indicators designed to determine whether the performance and resultant test score is valid. If a subtest's embedded validity indicator is flagged as "invalid", then domain scores derived from that subtest and the overall summary score are also flagged. The embedded validity indicators are automatically generated on the computer printout of the test results; therefore, they do not need to be calculated by the user. The calculations used by the computer program to determine each of the validity indicators are presented in Table 1 . These formulas, which were confirmed by the first author with the test publisher, were derived by the CNS Vital Signs company based on internal analyses of normative and clinical samples. The preliminary work on the development of these embedded validity indicators was presented at a conference (Gualtieri et al., 2009 ).
Stand-alone measures of performance validity. The criterion validity for the CNS Vital Signs embedded validity indicators was based on performance from two stand-alone PVTs-the Test of Memory Malingering (TOMM; Tombaugh, 1996) and the Victoria Symptom Validity Test (VSVT; Slick, Hopp, Strauss, & Thompson, 1997) . The TOMM is a forced-choice visual recognition PVT that has a low-presumed false-positive rate in healthy children (Constantinou & McCaffrey, 2003; Rienstra et al., 2010) and children with neurological disorders Donders, 2005; Loughan et al., 2012; MacAllister et al., 2009) . For information on the test format, please refer to the TOMM manual. The VSVT is a forced-choice visual recognition PVT that also has a low-presumed false-positive rate in youth with neurological diagnoses (Brooks, 2012) .
Neuropsychological measures. Additional neuropsychological tests were included in this study for the purpose of better describing the sample. The scores and tests included: General Ability Index from the Wechsler Intelligence Scale for Children, Fourth Edition (WISC-IV; Wechsler, 2003a) or the Wechsler Adult Intelligence Scale, Third/Fourth Edition (WAIS-III/IV; Wechsler, 1997 Wechsler, , 2008b ; the Processing Speed Index from the WISC-IV, WAIS-III, or WAIS-IV (Wechsler, 1997 (Wechsler, , 2003b (Wechsler, , 2008a ; the Continuous Attention Test (Seidel & Joschko, 1991) ; long delay free recall from the CVLT-C (Delis et al., 1994) or California Verbal Learning Test, Second Edition (Delis, Kramer, Kaplan, & Ober, 2000) ; and the general executive composite from the Behaviour Rating Inventory of Executive Function (Gioia, Isquith, Guy, & Kenworthy, 2000) .
Analyses
To examine the prevalence rates of being flagged on the CNS Vital Signs embedded validity indicators, patients were grouped into those who "passed" all seven embedded validity indicators and those who were "flagged" on one or more embedded validity indicators. Descriptive methods were used for performance on the CNS Vital Signs and the percent of patients being flagged as having an invalid score on the seven subtests. Comparing performance on the neuropsychological tests and stand-alone PVTs between those who "pass" and those who are flagged was completed using one-way analyses of variance and further described using Cohen's d effect sizes (d ¼ .20, small; d ¼ .50, medium; and d ¼ .80, large) .
Participants were also categorized into either "pass PVTs" [adequate performance on (a) the TOMM based on a score above published cutoffs and (b) the VSVT based on the computer printout indicating "valid" on both the easy and the hard items] or "questionable PVTs" [questionable performance on either (a) the TOMM based on a score below published cutoffs or (b) the VSVT based on the computer printout indicating "questionable" or "invalid" on either the easy or the hard items]. If only one PVT was administered with a patient, then performance of "pass PVT" or "questionable PVT" was based on that single test. Using the two groups created by the stand-alone PVTs (i.e., this served as the criterion validity measure), sensitivity and specificity were computed for the CNS Vital Signs embedded validity indicators. Sensitivity, defined as the probability of a positive test or the ability of the CNS Vital Signs EVI to detect questionable (below cutoff) performance based on the stand-alone PVTs, was computed based on: number of true positives/(number of true positives + number of false negatives). Specificity, defined as the probability of a negative test or the ability of the CNS Vital Signs embedded validity indicator to detect adequate (above cutoff) Saffer, Rosenblatt, et al., 2013) used the validity indicators that were published on the company website (www.cnsvs.com). There are some differences in the formulas in the table above, compared with the formulas published on the website in the past. The first author of the present study confirmed via email that the formulas in the table above are the correct formulas that were programmed into the software. Therefore, future researchers should use the formulas in the table above.
performance based on the stand-alone PVTs, was computed based on: number of true negatives/(number of true negatives + number of false positives).
Results
Participant demographics are presented in Table 2 (N ¼ 275). Participants in this study ranged in age from 7.0 to 18.9 years, with a mean age of 13.9 years (SD ¼ 3.0) and the majority of the sample being adolescents (18.9% were 7 -10 years, 38.9% were 11-14 years, and 42.2% were 15 -18 years). The sample was split fairly evenly with boys and girls, with the majority being Caucasian. Their parents were relatively well educated, with the majority identifying at least some level of post-secondary schooling. This sample included a heterogeneous range of neurological diagnoses, including those youth with epilepsy, traumatic brain injury, stroke, and hydrocephalus. The mean Neurocognition Index, a summary score of overall performance on the CNS Vital Signs, was 88.6 (SD ¼ 15.4) with 23.4% of the sample having a score 1.5 SD below the mean (note that this would be found in 7% of the standardization sample). The individual domain scores representing memory, processing and psychomotor speed, executive control, and reaction time ranged from 86.2 (SD ¼ 23.0; Complex Attention) to 95.7 (SD ¼ 18.5; Processing Speed). Between 16.9% and 31.8% of the sample had low domain scores when considering each domain individually. On the individual CNS Vital Signs subtests, a subtest score 1.5 SD below the mean was found in 7.0%-41.7% of the sample.
The percentages of the sample flagged on the various CNS Vital Signs embedded validity indicators are presented in Table 3 . With the exception of the Shifting Attention Test (12.6% of the sample flagged as "invalid" based on correct . errors) and the domain scores derived in part from this subtest (e.g., Executive Functions, 12.6% "invalid"; Complex Attention, 17.6% "invalid"; Cognitive Flexibility, 14.6% "invalid"), fewer than 5% of the sample were flagged on each of the other individual subtest and domain-embedded validity indicators. When considering all subtest embedded validity indicators simultaneously, 17.8% of the sample had one or more embedded validity indicators flagged by the program (this is also reflected with the same percent who are flagged on the Neurocognition Index summary score). In the present sample, having up to nine more errors than correct responses for the Shifting Attention Test embedded validity indicator would result in 4.6% of the sample being flagged as invalid (future research can help determine the best validity criterion for the Shifting Attention Test). Group comparisons between those who were or were not flagged on the CNS Vital Signs embedded validity indicators revealed statistically significant differences and large to very large effect sizes on age, overall cognitive/intellectual skills, psychomotor speed, verbal memory, and performance on stand-alone PVTs. Those patients who were flagged on one or more CNS Vital Signs embedded validity indicators were younger [F(1,211 When using performance on the stand-alone PVTs as the criterion for determining adequate or questionable performance, the sensitivity (true positive detection of questionable compliance) and specificity (true negative detection of questionable compliance) of the CNS Vital Signs embedded validity indicators was examined (see Table 4 ). Across the subtests, the CNS Vital Signs embedded validity indicators have sensitivity ranging from 0.04 to 0.29 and specificity ranging from 0.94 to 0.99. The highest sensitivity was obtained on the Shifting Attention Test (sensitivity ¼ 0.29), which improved marginally to 0.35 when considering an adjusted embedded validity indicator derived for the present sample (correct errors ≥ 29). It is worth noting that several domain scores are based on single subtests (e.g., Verbal Memory Domain, Visual Memory Domain, Processing Speed Domain, Executive Functions Domain, and Reaction Time Domain), so the sensitivity and specificity values are identical to those presented for the respective subtests. When considering the remaining domain scores that are based on multiple subtests, sensitivity ranged from 0.12 to 0.35 and specificity ranged from 0.88 to 0.99. For the Neurocognition Index, sensitivity was 0.39 and specificity was 0.89. Notes: Above or below the cutoff for an embedded validity indicator is based on the calculations provided in Table 1 . 
Discussion
There are very few published studies examining embedded performance validity indicators in children and adolescents. To our knowledge, this is the first study to do so using the CNS Vital Signs battery. In this large sample of youth with neurological diagnoses, the fail rate was very low across all but one of the individual tests (i.e., 5% or fewer were flagged as invalid on six of seven subtests). Generally, a .90% pass rate in children and adolescents on an individual PVT is considered clinically useful, especially when it is found in a sample with known cognitive impairment (Brooks, 2012; Carone, 2008; Donders, 2005; Donders & Boonstra, 2007; Green & Flaro, 2003; Green et al., 2009; Kirkwood & Kirk, 2010; MacAllister et al., 2009; Perna & Loughan, 2013) . The exceptions to the very high pass rate were the Shifting Attention Test (87.4%) and three domain scores (Executive Functions, 87.4% passed; Complex Attention, 82.4% passed; and Cognitive Flexibility, 85.4% passed) .
When considering all of the embedded validity indicators from the seven subtests simultaneously, nearly 18% of the sample had at least one flagged validity indicator (this value is also reflected in the pass rate on the Neurocognition Index). Those children and adolescents with one or more flagged validity indicators were younger, and they had lower cognitive/intellectual abilities, worse psychomotor processing speed, worse verbal memory, and worse performance on the two stand-alone PVTs.
When the CNS Vital Signs embedded validity indicators were compared with external criterion stand-alone PVTs (i.e., the TOMM and VSVT), specificity was adequate-to-high but sensitivity for identifying possible poor effort was often low. On the seven subtests, specificity of the embedded validity indicators was very high (ranging from 0.94 to 0.99). Specificity for the domain scores was also quite high (ranging from 0.88 to 0.99), although the Complex Attention domain (specificity ¼ 0.88) and Neurocognition Index (specificity ¼ 0.89) were slightly under the desired 90% level of specificity. Sensitivity values of the CNS Vital Signs embedded validity indicators, however, were quite low for all of the subtests (sensitivity ¼ 0.04 -0.29) and most of the domains, suggesting that these indicators may not be able to detect invalid test scores (assuming that unusually low performance on the TOMM or VSVT would also be associated with questionably valid scores on CNS VS). In other words, the validity indicators might not detect the majority of children and adolescents who are identified as having invalid scores on stand-alone PVTs such as the TOMM and VSVT (i.e., they have a high miss rate). Given that the specificity is so high, it might be helpful to investigate embedded validity indicators in a pediatric sample that is instructed to simulate malingering. Simulation research might advance our understanding of deliberately poor effort in children and adolescents, and lay the foundation for the development of more sensitive embedded indicators on CNS Vital Signs.
Based on the information available on the company website, several unpublished conference presentations, and the current study, three conclusions can be made. First, the extent to which the CNS Vital Signs embedded validity indicators identify deliberately poor performance, misunderstanding regarding how to take the test, or both is unknown. We cannot assume that a score flagged as invalid represents volitional poor performance; it might reflect misunderstanding or even cognitive impairment in some children. Second, there is a pressing need for analog malingering studies in children, adolescents, and adults to better understand how people underperform on this test battery. Third, more research is needed on how confusion or misunderstanding on the part of the participant, regarding the test instructions or procedures, influences the probability of being flagged by a validity indicator.
The low sensitivity and high specificity of the CNS Vital Signs embedded validity indicators in this sample is not unique. Prior studies have reported high specificity (.90%) at the sacrifice of lower sensitivity on the RDS (ranging from 20% in patients with epilepsy to 51% in patients with mTBI; Kirkwood et al., 2011; Loughan et al., 2012; Welsh et al., 2012) and the CMS Verbal Delayed Memory measures (11% in children referred for behavioral and academic reasons; Perna et al., 2014) .
There are some limitations of this study. The sample consists of mixed neurological diagnoses, representing those patients who are referred for a neuropsychological assessment within our tertiary care hospital; it is not representative of all children and adolescents with a neurological diagnosis. However, it is representative of the population assessed within this specific environment, where a rapid evaluation of cognitive abilities may be desired in order to screen functioning. Second, there is a limitation on the stand-alone PVTs used for comparison in this study. Although there is burgeoning evidence for the use of the TOMM in pediatric samples (see DeRight & Carone, in press; Kirkwood, 2012 for a review), there is currently only one study illustrating the use of the VSVT in pediatric patients (Brooks, 2012) .
On six of seven subtests, the CNS Vital Signs embedded validity indicators have low rates of being flagged (i.e., the exception is the Shifting Attention Test). Users should bear in mind, however, that when all validity indicators were considered simultaneously in the present study, nearly one in five children with a neurological diagnosis had a flagged score. Despite adequate-to-high specificity, most of the CNS Vital Signs embedded validity indicators have low sensitivity when compared with stand-alone PVTs. The exceptions may be the Complex Attention (sensitivity ¼ .35) and Cognitive Flexibility (sensitivity ¼ .32) domains, although these are below our a priori desired level of 0.5. Further studies on the utility of the CNS Vital Signs embedded validity indicators are needed, with studies in healthy children, those ask to simulate malingering, other clinical groups, and additional adult samples before a conclusive determination on the sensitivity, specificity, and clinical usefulness of these indicators can be achieved.
